Boeing, SPEEA Reach Tentative Four-Year Labor Deal 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028 
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation 
Nvidia Plans 2GW Australia AI Data Center Expansion by 2027 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Google Revamps EU Search Results to Meet DMA Rules 
Japanese Yen Nears Seven-Month High as Oil Approaches $100 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak 
Gulf Ministers to Meet Iran in Oman Over Hormuz Shipping Deal 
Add as a preferred source on Google
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
